Addition of pulsed electric field ablation to SBRT for lung tumors: effect on health-related quality of life.
OpenAlex 토픽 ·
Microbial Inactivation Methods
Hepatocellular Carcinoma Treatment and Prognosis
Cardiac Arrhythmias and Treatments
[INTRODUCTION] Treatment indications for oligometastatic/oligoprogressive lung tumors are growing.
APA
Jeremy P. Harris, Christina Boyd, et al. (2026). Addition of pulsed electric field ablation to SBRT for lung tumors: effect on health-related quality of life.. Lung cancer management, 15(1), 2635332. https://doi.org/10.1080/17581966.2026.2635332
MLA
Jeremy P. Harris, et al.. "Addition of pulsed electric field ablation to SBRT for lung tumors: effect on health-related quality of life.." Lung cancer management, vol. 15, no. 1, 2026, pp. 2635332.
PMID
41783980
Abstract
[INTRODUCTION] Treatment indications for oligometastatic/oligoprogressive lung tumors are growing. Safety and lack of detrimental effect on patients' quality of life are critical for novel local therapies.
[METHODS] We tested that the additive effect of pulsed electric field (PEF) ablation with lower-dose stereotactic body radiation therapy (SBRT) on health-related quality of life (HRQoL) as a secondary endpoint in a prospective clinical trial. FACT-Lung Cancer Subscale (FACT-LCS) and FACT-General domain surveys were collected at screening, 3 months, and 12 months. Functional clinical data included forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and diffusing capacity of the lung for carbon monoxide (DLCO).
[RESULTS] Six patients with eight tumors were enrolled. Baseline well-being domain scores were: Physical 25.9 (Std Dev 2.3), Social 21.0 (Std Dev 6.9), Emotional 17.3 (Std Dev 4.7), Functional 21.2 (Std Dev 5.8), and LCS 19.4 (Std Dev 5.3). There were no significant changes following combined modality treatment in HRQoL domain scores or pulmonary function metrics after treatment. Lower EWB and SWB were associated with worse FVC and FEV1.
[CONCLUSION] In this small pilot study, no clinically meaningful declines in pulmonary function or patient-reported quality of life were observed at 3 months following combination therapy.
[METHODS] We tested that the additive effect of pulsed electric field (PEF) ablation with lower-dose stereotactic body radiation therapy (SBRT) on health-related quality of life (HRQoL) as a secondary endpoint in a prospective clinical trial. FACT-Lung Cancer Subscale (FACT-LCS) and FACT-General domain surveys were collected at screening, 3 months, and 12 months. Functional clinical data included forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and diffusing capacity of the lung for carbon monoxide (DLCO).
[RESULTS] Six patients with eight tumors were enrolled. Baseline well-being domain scores were: Physical 25.9 (Std Dev 2.3), Social 21.0 (Std Dev 6.9), Emotional 17.3 (Std Dev 4.7), Functional 21.2 (Std Dev 5.8), and LCS 19.4 (Std Dev 5.3). There were no significant changes following combined modality treatment in HRQoL domain scores or pulmonary function metrics after treatment. Lower EWB and SWB were associated with worse FVC and FEV1.
[CONCLUSION] In this small pilot study, no clinically meaningful declines in pulmonary function or patient-reported quality of life were observed at 3 months following combination therapy.